Skip to content

Factors determining the efficacy of management of shoulder adhesive capsulitis secondary to breast cancer treatment

Factors determining the efficacy of guided intervention-based management of shoulder adhesive capsulitis secondary to breast cancer treatment: A prospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/12/048409
Enrollment
60
Registered
2022-12-22
Start date
Unknown
Completion date
Unknown
Last updated
2023-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M968- Other intraoperative and postprocedural complications and disorders of musculoskeletal system, not elsewhere classified

Interventions

Intervention1: Suprascapular nerve block and Glenohumeral joint hydrodilatation: Suprascapular nerve block with 8 mL of 0.25% bupivacaine and glenohumeral joint hydro-dilatation with 40 mg triamcinolo

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed case of shoulder adhesive capsulitis secondary to breast cancer who have been treated with curative surgery and have received or receiving post operative radiation therapy (RT) will be included. The first diagnosis of breast cancer should not be more than 5 years back.

Exclusion criteria

Exclusion criteria: Patient who had received steroid injection treatment for shoulder pain in last 1 month. Those patients who had metastatic disease. Known disorder of ipsilateral shoulder ex. Arthritis, fracture, Rotator cuff tendon tear, Avascular necrosis of head of humerus Patients initially classified as adhesive capsulitis but the final diagnosis changed to other causes of shoulder pain. Patients initially classified as adhesive capsulitis but the treating Physiatrist chose to follow an alternate management regimen. Those patients who are not willing to participate in study.

Design outcomes

Primary

MeasureTime frame
Shoulder Pain And Disability Index (SPADI) and Visual Analogue Scale (VAS)Timepoint: 0 weeks, 2 weeks, 1 month and 3 months

Secondary

MeasureTime frame
Functional Independence Measure scoreTimepoint: Two weeks One month Three months

Countries

India

Contacts

Public ContactDr Ravi Gaur

AIIMS, Jodhpur

ravisms80@gmail.com829971153

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026